Introduction to Immune Checkpoint Inhibitors in Practice MasterClass - US edition

This event will help to develop knowledge on the use of immunotherapy in oncology patients. On top of that we will discuss toxicity management and funding streams of the medications across the UK

27-28 May, 2026, Virtual

STARTING TIME 08:00 A.M. EDT | 05:00 A.M. PDT | 12:00 UTC

Overview

Cancer treatment has evolved into an era where the immune system is no longer a spectator but a central player. This session provides a focused introduction to cancer biology and the immune response, followed by an exploration of modern immunotherapy approaches and their therapeutic targets. We will examine immune-related adverse events, complex toxicities, and practical management challenges that accompany these powerful treatments. Beyond the science, the masterclass addresses real-world patient journeys, access and funding considerations, and the realities of clinical implementation.The session concludes with a forward look at emerging therapies and the future direction of immuno-oncology, connecting innovation with everyday practice.

This event will help to develop knowledge on the use of immunotherapy in oncology patients. On top of that, we will discuss toxicity management and funding streams of the medications across the UK

#masterclass     #glceurope      #pharma      #globaltraining      #immune      #immunotherapy      #inhibitors

WHO SHOULD ATTEND

-Medical representatives

-Medical oncologist, hematologist

-Oncology Pharmacists

-Doctors

-Oncology Nurses

-Immunologist

-PV managers, drug safety physician

-Clinical trial manager

-Director of oncology